Clinical Trials Directory

Trials / Terminated

TerminatedNCT03161444

Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
354 (actual)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will estimate the cumulative incidence of Zika infection at the end of the first epidemic in the French West Indies in a sample of patients followed for HIV infection.

Detailed description

Zika virus infection is expanding in all tropical and subtropical areas. The presence of Aedes albopictus in southern France raises concerns about the occurrence of outbreaks of indigenous Zika virus transmission. In this context, knowledge of the cumulative impact of the epidemic that affected the Caribbean in 2016 is an important issue for the management of future epidemics and modeling work. Since the Zika virus has not yet been circulated in the Lesser Antilles, the cumulative incidence rate can be estimated by conducting a general population seroprevalence survey at the end of the epidemic, or more simply within a cohort of patients regularly monitored and whose habitat is distributed throughout the study area. Thus, HIV-infected patients who benefit from regular clinical biological monitoring constitute a population sample perfectly adapted to the study of the emergence of the Zika virus in the French West Indies. The cumulative incidence of infection with the chikungunya virus after the 2014 epidemic has thus been estimated at 58% for Martinique and Guadeloupe using this method.

Conditions

Interventions

TypeNameDescription
OTHERBiological sample collectionA blood sample collection for the study will be taken to each participant Each subject enrolled must have previously participated to the study CHIKVIH.

Timeline

Start date
2017-03-21
Primary completion
2019-08-10
Completion
2020-03-02
First posted
2017-05-19
Last updated
2022-03-21

Locations

2 sites across 2 countries: Guadeloupe, Martinique

Source: ClinicalTrials.gov record NCT03161444. Inclusion in this directory is not an endorsement.